Aprea Therapeutics, Inc. (APRE) |
| 0.6962 -0.032 (-4.42%) 07-15 13:09 |
| Open: | 0.715 |
| High: | 0.7282 |
| Low: | 0.6902 |
| Volume: | 23,482 |
| Market Cap: | 5(M) |
| PE Ratio: | -0.45 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.85 |
| Resistance 1: | 0.76 |
| Pivot price: | 0.76 |
| Support 1: | 0.61 |
| Support 2: | 0.51 |
| 52w High: | 2.22 |
| 52w Low: | 0.548 |
Aprea Therapeutics, Inc. is a biopharmaceutical company in its clinical development stage, dedicated to discovering and marketing innovative cancer treatments. Their therapeutic approach centers on modulating DNA damage response pathways. The company's primary drug candidate, ATRN-119, is an oral ATR inhibitor currently undergoing Phase 1/2a clinical trials for patients with advanced solid tumors. Beyond this lead compound, Aprea's developmental pipeline includes ATRN-Backup, which is also an ATR inhibitor; ATRN-W1051, being explored for its anti-tumor effects; and ATRN-DDRi. Aprea Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Financials
| EPS | -12560000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -10.00 |
| Return on Assets (ttm) | 202.0 |
| Return on Equity (ttm) | -23.2 |
Company news
Mon, 06 Jul 2026
Enterprise value to EBITDA forward of Aprea Therapeutics, Inc. – NASDAQ:APRE - TradingView
Fri, 26 Jun 2026
APRE Forecast — Price Target — Prediction for 2027 - TradingView
Thu, 28 May 2026
Aprea Therapeutics (APRE) Edges Higher Amid Low Volume Trading - Triple MA Cross - DonanımHaber
Thu, 28 May 2026
Aprea Therapeutics (APRE) Gains 2.78% as Shares Approach Key Resistance at $0.99 - Day Trade Opportunities - dars.gov.et
Wed, 13 May 2026
Aprea Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
Wed, 13 May 2026
Aprea Therapeutics (NASDAQ:APRE) Q1 2026 Results: Clinical Progress Drives Stock Higher - ChartMill
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
